![Jim DeNike](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Jim DeNike currently works at MBX Biosciences, Inc., as Investor Relations Contact.
Mr. DeNike also formerly worked at Emergent Product Development Seattle, as Senior Director-Corporate Communications, NS Wind Down Co., Inc., as Senior Director-Corporate Communications & IR, Marinus Pharmaceuticals, Inc., as Senior Director-Investor Relations from 2023 to 2024, OncoGenex Pharmaceuticals, Inc., as Investor Relations Contact, and Acer Therapeutics, Inc., as Investor Relation Contact.
Aktive Positionen von Jim DeNike
| Unternehmen | Position | Beginn |
|---|---|---|
| MBX BIOSCIENCES, INC. | Investor Relations Kontakt | - |
Ehemalige bekannte Positionen von Jim DeNike
| Unternehmen | Position | Ende |
|---|---|---|
| MARINUS PHARMACEUTICALS, INC. | Investor Relations Kontakt | 01.05.2024 |
| ACER THERAPEUTICS INC. | Investor Relations Kontakt | 01.08.2023 |
| NS WIND DOWN CO., INC. | Public Communications Contact | 01.11.2014 |
OncoGenex Pharmaceuticals, Inc.
 OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies that address treatment resistance in cancer patients | Investor Relations Kontakt | - |
Emergent Product Development Seattle
 Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Discovers and develops biopharmaceutical products | Public Communications Contact | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
18
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Emergent Product Development Seattle
Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Discovers and develops biopharmaceutical products | Health Technology |
Marinus Pharmaceuticals, Inc.
 Marinus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for rare genetic epilepsies and other seizure disorders | Health Technology |
NS Wind Down Co., Inc.
 NS Wind Down Co., Inc. Medical SpecialtiesHealth Technology Develops and manufactures life science tools for translational research and molecular diagnostic products | Health Technology |
OncoGenex Pharmaceuticals, Inc.
OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies that address treatment resistance in cancer patients | Health Technology |
Acer Therapeutics, Inc.
 Acer Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes therapies for serious rare and life-threatening diseases | Health Technology |
MBX Biosciences, Inc.
 MBX Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company focused on discovery and development of novel precision peptide therapies for endocrine & metabolic disorders | Health Technology |
